Overexpression of HOXA10 played a pivotal role in promoting EMT and GC metastasis by modulating TGFB2/Smad/METTL3 signaling axis, thus might help provide a novel candidate for GC treatment and develop new therapeutic strategies for GC metastasis. Here, TGFB2 is linked to gastric cancer.